SUMMARY
Acute kidney injury is associated with increased risk of heart failure and mortality. This study demonstrates that acute kidney injury induces remote cardiac dysfunction, damage, injury, and fibrosis via a galectin-3 (Gal-3) A cute kidney injury (AKI) has been associated with an increased risk of mortality (1) , even in patients free of previous cardiovascular comorbidities (2) . Furthermore, AKI has been associated with long-term cardiovascular events (3) .
Whether the occurrence of AKI only reflects the severity and magnitude of underlying disease or may contribute to remote organ injury remains uncertain. Remote cardiovascular injury may contribute to poor outcomes after AKI (4) . AKI has also been associated with long-term cardiovascular events. This has been described in type 3 cardiorenal syndrome (or acute reno-cardiac syndrome) (5) .
However, whether transient AKI can induce longterm cardiac injury remains unexplored. Cardiac fibrosis has been described as a key feature of chronic heart diseases (6) . Galectin-3 (Gal-3) is a lectin that specifically binds to b-galactosides (7) expressed in many tissues, including the heart and kidney (8, 9) .
In the heart, Gal-3 induction promotes myocardial fibrosis and heart failure progression (10, 11) . has been shown to be a key player in cardiac fibrosis induction and has been proposed as a prognostic biomarker for chronic heart failure (7) . In the kidney, Gal-3 has also been shown to be upregulated after AKI (12) . In the present study, we hypothesized that AKI can activate Gal-3Àdependent pathways and promote cardiac injury. For this purpose, we explored the role of Gal-3 in cardiac injury after kidney injury. Moreover, a bone marrow (BM) graft from Gal-3 knock-out (KO) mice was used to determine the origin of Gal-3. (lymphocyte marker), F4/80 (macrophage marker), and GR1 (neutrophil marker) only showed co-localization of Gal-3 with F4/80, indicating that it was also expressed by infiltrated macrophages within the injured renal tissue after 24 h of IR (white arrows). n ¼ 7 to 14 for WT IR groups; n ¼ 4 to 7 for KO IR; n ¼ 4 for WT and n ¼ 4 KO Gal-3 sham mice. Data are presented as mean AE SEM, and comparisons of medians were made using nonparametric Mann-Whitney U test. *p < 0.05. Gal-3 Promotes Cardiac Damage After Kidney Injury Figure 1A ). Another mouse group was submitted to left femoral artery occlusion for 25 min, followed by reperfusion. These mice were killed 28 days after surgery (hind limb ischemia).
B o n e m a r r o w t r a n s p l a n t a t i o n . Mice were irradiated at 10 grays (2 Â 5 grays at 5-h interval) with filter, Figure 1C ). Gal-3 Promotes Cardiac Damage After Kidney Injury Prud'homme et al. was considered statistically significant. Figure 3 ). This increase was followed by an increase in cardiac Gal-3 expression at 48 h (Figure 2A) , which was confirmed at the protein level ( Figures 2B and 2C) . Cardiac tissue infiltration by inflammatory cells and systemic inflammation assessed with plasma cytokines and adhesion molecule levels measurements were observed during the first 72 h after IR. Plasma levels of Gal-3 increased, with a peak at 72 h, and remained elevated until day 28 ( Figure 2D ). CD68 mRNA expression increased in the heart at 48 h ( Figure 2E ). Furthermore, hearts showed CD68 þ cells (infiltrating macrophages) ( Figure 2F) was increased ( Figure 3A) . Furthermore, CD68 þ and Gal-3 þ cells ( Figure 3B ) and increased collagen areas ( Figures 3C and 3D) were observed.
RESULTS
Although cardiac function was normal during the first 72 h, IR induced a late increase in left ventricular diastolic diameter (Supplemental Table 1 ) and a decrease in fractional shortening ( Figure 3E) 28 days after injury. At the anatomical level, kidney hypertrophy was observed 28 days after AKI and was not prevented by MCP treatment (Supplemental Table 1 ).
Hind limb ischemia did not lead to cardiac dysfunction and injury, or changes in Gal-3 expression (Supplemental Figure 5 ). Table 2 ). Plasma Gal-3 levels were close to zero in sham WT KO BM mice. Furthermore, in response to renal IR, plasma Gal-3 levels were higher in KO WT BM than in WT KO BM mice ( Figure 4A) . No variation in plasmatic IL-6 levels was observed at 28 days post-IR ( Figure 4B) . Cardiac CD146 and MCP-1 mRNA levels, an endothelial and inflammatory marker, respectively, were lower in IR WT KO BM mice versus KO WT BM mice ( Figures 4C and 4D ). Cardiac Gal-3 mRNA expression did not change between sham and IR mice but varied according to mice genotype.
However, Gal-3 protein expression was slightly increased at 28 days after IR (Supplemental Figure 6 ).
Cardiac Gal-3 mRNA expression was higher in KO WT BM mice than in WT KO BM mice ( Figure 4E) . Moreover, an increase in ICAM-1 mRNA expression was observed in response to IR only in KO WT BM mice ( Figure 4F ).
Furthermore, Sirius red staining showed a significant increase in cardiac interstitial fibrosis in response to IR in KO WT BM mice compared with sham mice, which was blunted in WT KO BM mice ( Figure 4G ).
Echocardiography revealed a decrease in fractional
shortening after IR only in KO WT BM mice ( Figure 4H ).
Finally, CD68/Gal-3 co-staining in cardiac tissue showed CD68 þ /Gal-3 þ cells in KO WT BM mice, whereas CD68 þ cells in WT KO BM mice were Gal-3 À (Figure 4I) . Figure 7B ). An increase in tubular dilatation was observed in both UUO and UUOþMCP mice at 15 days; an increase in right kidney weight (i.e., renal hypertrophy) was also observed at 2 months (Supplemental Figure 7B , Supplemental   Table 3 ). Plasma levels of TNF-a, IL-6, IL-1b, and IL-10 were also increased after UUO and peaked at 28 days, except for IL-1b, which rapidly increased after surgery, peaked at 7 days, and then decreased and returned to baseline. The increase of cytokine levels was prevented by MCP treatment (Figure 5A , Figure 5C ) and by an increase of interstitial collagen areas ( Figure 5D ). MCP treatment prevented fibrosis (Figures 5C and 5D ). Importantly, UUO Prud'homme et al. PS-matching and the red points MSD after PS-matching). Abbreviations as in Figure 1 . Table 5 ).
DISCUSSION
In this study, we explored the impact of AKI on remote cardiac injury. Results showed that renal IR Our findings provided important insights into cardiorenal syndrome type 3 or acute reno-cardiac syndrome (AKI leading to cardiac injury) pathophysiology (19) . We hypothesized that AKI triggers the secretion of Gal-3, which promotes the development of cardiac injury by generating fibrosis.
Occurrence of AKI was associated with both shortand long-term risk of mortality in different settings (1) . Furthermore, there was increasing evidence that AKI is associated with a risk of cardiovascular events (3, 20) . Recently, Go et al. (21) explored the association between AKI and the risk of cardiovascular events during the year following hospital discharge. Using a large database with propensity score matching, they observed that AKI was a risk factor for heart failure during the year following discharge. Such cardiovascular consequences of AKI may be causal (at least partially) in the poor outcomes of the injury. In this study, we explored the association between AKI and circulating expression of Gal-3 and cardiac injury in critically ill patients. We observed that patients who presented with AKI during ICU stay and survived had higher plasma Gal-3 levels at discharge, along with high plasma levels of biomarkers of cardiac injury and failure. Although renal function did affect the level of natriuretic peptides and troponin, eGFR did not appear to be the major determinant of these cardiac biomarker levels (22) . Recent data showed similar diurnal variation in patients with and without chronic kidney disease, which suggested that decreased clearance is not the primary mechanism for elevated high-sensitivity cardiac troponin levels in the patients with renal failure (23). Importantly, elevated levels of natriuretic peptides and troponin were associated in many studies with cardiovascular events and outcome (24, 25) . Therefore, these biomarkers are still considered valid biomarkers of cardiovascular events in patients with renal failure.
Finally, patients with AKI but who were discharged with eGFR >60 ml/min/1.73 m 2 showed elevated plasma biomarkers of cardiac damage compared with patients without AKI (Supplemental Table 5 ).
We used preclinical models to explore the pathophysiological roles of Gal-3 after AKI. In our models, acute cardiac response to renal injury was characterized by an early increase in plasmatic cytokine levels and cardiac injury. The acute cardiac response was followed by a late cardiac response that was characterized by systolic dysfunction and cardiac fibrosis. echocardiography at 72 h (28) . In another study, the macrophage chemokine osteopontin was increased, along with macrophage infiltration in the heart after 24 h of renal IR (29) . In addition, increased TNF-a, IL-6, and IL-1b plasma concentrations were observed 3 h after renal IR (30) . In our model, cytokine assays showed increased plasma cytokine levels in response to AKI during the acute stage (6 to 48 h). This increase was prevented in MCP-treated and Gal-3 KO mice.
Martinez-Martinez et al. (8) showed that experimental hyperaldosteronism leads to cardiac fibrosis in a
Gal-3Àdependent pathway that is independent of blood pressure (8) . The results from our study showed that AKI promoted Gal-3Àdependent cardiac injury and inflammation, fibrosis, and systolic dysfunction.
Recently, macrophages were identified as key players in the development of heart failure (31) . AKI can induce systemic sympathetic nervous system and renin-angiotensin-aldosterone system activation (35) . Although the increase in systemic arterial pressure was not sustained, increased vascular reactivity to angiotensin II was reported (36) .
Our group and others showed that activation of the renin-angiotensin-aldosterone system could promote cardiac and renal injuries (10, 11) . We explored the source of Gal-3 in our models.
Gal-3 can be expressed in different cell types including tubular and immune cells (37) . In our model of renal IR, damaged tubules expressed Gal-3 and might also be the source of pro-inflammatory cytokine expression. In this study, the question of the source of cardiac Gal-3 after AKI was mainly explored using BM transplantation. We showed that renal IR led to an increase in Gal-3 expression, cardiac fibrosis, and dysfunction in WT mice, but this damage was prevented in WT KO BM mice. Furthermore, we 
